Endocuff + GI Genius for Colon Cancer Detection
Trial Summary
What is the purpose of this trial?
Despite the widespread use of colonoscopy, the ongoing challenge of potentially missing polyps remains. Previous studies have independently shown that both Endocuff, a colonoscope attachment device for polyp detection, and Computer-Aided Detection (CADe) systems have individually demonstrated enhanced lesion detection and safety. This study seeks to evaluate the efficacy of combining the Endocuff CADe versus using CADe alone in colonoscopy procedures for colorectal cancer screening and surveillance. This research project aims to ascertain whether the synergistic application of these technologies yields superior outcomes.
Research Team
Wesam Frandah, MD
Principal Investigator
Marshall University Joan C. Edwards School of Medicine
Eligibility Criteria
This trial is for adults over 18 who are due for a routine outpatient colonoscopy to screen or monitor for colorectal cancer. It's not suitable for pregnant individuals, those with severe colitis, bowel obstructions, history of colon surgery, hereditary polyposis syndrome, untreated colon cancer or on continuous anti-thrombotic therapy.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo colonoscopy procedures using either the Endocuff with CADe or CADe alone for colorectal cancer screening and surveillance
Follow-up
Participants are monitored for adenoma detection rate and safety after the colonoscopy procedure
Treatment Details
Interventions
- CADe
- Endocuff
Find a Clinic Near You
Who Is Running the Clinical Trial?
Marshall University
Lead Sponsor